Fountain Nathan B has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 12800 shares of Acumen Pharmaceuticals, Inc. ($ABOS) on June 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Fountain Nathan B | Director | A | Common Stock | 12800 | $0.00 | 19,050.0000 | 60,573,425 | 204.80% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Fountain Nathan B | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Fountain Nathan B | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Fountain Nathan B | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |